Current through Register Vol. 48, No. 9, September 27, 2024
4.23.1 Training for Experienced Radiation
Safety Officer, Teletherapy or Medical Physicist, and Nuclear Pharmacist.
4.23.1.1 An individual identified on a
Nuclear Regulatory Commission or an Agreement State license or a permit issued
by a Nuclear Regulatory Commission or an Agreement State broad scope licensee
or master material license permit or by a master material license permittee of
broad scope as a Radiation Safety Officer, a teletherapy or medical physicist,
an authorized medical physicist, a nuclear pharmacist or an authorized nuclear
pharmacist on or before January 14, 2019, need not comply with the training
requirements of
RHA 4.20, RHA 4.21, or RHA
4.22, respectively, except the Radiation Safety Officers and authorized medical
physicists identified in this paragraph must meet the training requirements in
RHA 4.20.4 or RHA 4.21.3,
as appropriate, for any material or uses for which they were not authorized
prior to this date.
4.23.1.2 Any
individual certified by the American Board of Health Physics in Comprehensive
Health Physics; American Board of Radiology; American Board of Nuclear
Medicine; American Board of Science in Nuclear Medicine; Board of
Pharmaceutical Specialties in Nuclear Pharmacy; American Board of Medical
Physics in radiation oncology physics; Royal College of Physicians and Surgeons
of Canada in nuclear medicine; American Osteopathic Board of Radiology; or
American Osteopathic Board of Nuclear Medicine on or before October 24, 2005,
need not comply with the training requirements of
RHA 4.20 to be identified as
a Radiation
Safety Officer or as an Associate Radiation Safety Officer
on a Nuclear Regulatory Commission or an Agreement State license or Nuclear
Regulatory Commission master material license permit for those materials and
uses that these individuals performed on or before October 24, 2005.
4.23.1.3 Any individual certified
by the American Board of Radiology in therapeutic radiological physics,
Roentgen ray and gamma ray physics, x-ray and radium physics, or radiological
physics, or certified by the American Board of Medical Physics in radiation
oncology physics, on or before October 24, 2005, need not comply with the
training requirements for an authorized medical physicist described in
RHA 4.21, for those
materials and uses that these individuals performed on or before October 24,
2005.
4.23.1.4 A Radiation Safety
Officer, a medical physicist, or a nuclear pharmacist, who used only
accelerator-produced radioactive materials, discrete sources of radium-226, or
both, for medical uses or in the practice of nuclear pharmacy at a Government
agency or Federally recognized Indian Tribe before November 30, 2007, or at all
other locations of use before August 8, 2009, or an earlier date as noticed by
the Nuclear Regulatory Commission, need not comply with the training
requirements of
RHA 4.20, RHA 4.21, or RHA
4.22, respectively, when performing the same uses. A nuclear pharmacist, who
prepared only radioactive drugs containing accelerator-produced radioactive
materials, or a medical physicist, who used only accelerator-produced
radioactive materials, at the locations and during the time period identified
in this paragraph, qualifies as an authorized nuclear pharmacist or an
authorized medical physicist, respectively, for those materials and uses
performed before these dates, for the purposes of this
chapter.
4.23.2 Training
for Experienced Authorized User
4.23.2.1
Physicians, dentists, or podiatrists identified as authorized users for the
medical use of radioactive material on a license issued by the Nuclear
Regulatory Commission or an Agreement State, a permit issued by a Nuclear
Regulatory Commission master material licensee, a permit issued by a Nuclear
Regulatory Commission or an Agreement State broad scope licensee, or a permit
issued by a Nuclear Regulatory Commission master material license broad scope
permittee on or before January 14, 2019, who perform only those medical uses
for which they were authorized on or before that date need not comply with the
training requirements of subparts D through H of this part.
4.23.2.2 Physicians, dentists, or podiatrists
not identified as authorized users for the medical use of radioactive material
on a license issued by the Nuclear Regulatory Commission or an Agreement State,
a permit issued by a Nuclear Regulatory Commission master material licensee, a
permit issued by a Nuclear Regulatory Commission or an Agreement State broad
scope license, or a permit issued in accordance with a Commission master
material license of broad scope on or before October 24, 2005, need not comply
with the training requirements of subparts D through H of this part for those
materials and uses that these individuals performed on or before October 24,
2005, as follows:
4.23.2.2.1 For uses
authorized under
RHA 4.35 or RHA 4.37, or
oral administration of sodium iodide I- 131 requiring a written directive for
imaging and localization purposes, a physician who was certified on or before
October 24, 2005, in nuclear medicine by the American Board of Nuclear
Medicine; diagnostic radiology by the American Board of Radiology; diagnostic
radiology or radiology by the American Osteopathic Board of Radiology; nuclear
medicine by the Royal College of Physicians and Surgeons of Canada; or American
Osteopathic Board of Nuclear Medicine in nuclear medicine;
4.23.2.2.2 For uses authorized under
RHA 4.40, a physician who
was certified on or before October 24, 2005, by the American Board of Nuclear
Medicine; the American Board of Radiology in radiology, therapeutic radiology,
or radiation oncology; nuclear medicine by the Royal College of Physicians and
Surgeons of Canada; or the American Osteopathic Board of Radiology after
1984;
4.23.2.2.3 For uses
authorized under
RHA 4.46 or RHA 4.58, a
physician who was certified on or before October 24, 2005, in radiology,
therapeutic radiology or radiation oncology by the American Board of
Radiology; radiation oncology by the American Osteopathic
Board of Radiology; radiology, with specialization in radiotherapy, as a
British "Fellow of the Faculty of Radiology" or "Fellow of the Royal College of
Radiology"; or therapeutic radiology by the Canadian Royal College of
Physicians and Surgeons; and
4.23.2.2.4 For uses authorized under
RHA 4.56, a physician who
was certified on or before October 24, 2005, in radiology, diagnostic
radiology, therapeutic radiology, or radiation oncology by the American Board
of Radiology; nuclear medicine by the American Board of Nuclear Medicine;
diagnostic radiology or radiology by the American Osteopathic Board of
Radiology; or nuclear medicine by the Royal College of Physicians and Surgeons
of Canada.
4.23.2.3
Physicians, dentists, or podiatrists who used only accelerator-produced
radioactive materials, discrete sources of radium-226, or both, for medical
uses performed at a Government agency or Federally recognized Indian Tribe
before November 30, 2007, or at all other locations of use before August 8,
2009, or an earlier date as noticed by the Nuclear Regulatory Commission, need
not comply with the training requirements of subparts D through H of this part
when performing the same medical uses. A physician, dentist, or podiatrist, who
used only accelerator-produced radioactive materials, discrete sources of
radium-226, or both, for medical uses at the locations and time period
identified in this paragraph, qualifies as an authorized user for those
materials and uses performed before these dates, for the purposes of this
chapter.